Efficacy and Safety of IL-11 in DDAVP Unresponsive
NCT00994929
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
9
Enrollment
OTHER
Sponsor class
Conditions
Hemophilia A
Von Willebrand Disease
Interventions
BIOLOGICAL:
Neumega (Oprelvekin, Interleukin 11, IL-11)
Sponsor
University of Pittsburgh